Ctrl

K

Table of contents

Expand All Topics

Acute cystitis

What's new

The European Association of Urology (EAU) has published an annual update to its guidelines on urological infections. The updated guidelines propose a new classification for urinary tract infections (UTIs), replacing the terms "uncomplicated" and "complicated" with a distinction between localized UTIs (i.e., cystitis) and systemic UTIs (e.g., acute pyelonephritis, acute bacterial prostatitis, urosepsis). Both types can occur in either sex and may be accompanied by risk factors. The revised guidelines also include a new weak recommendation, based on recent randomized clinical trials and a meta-analysis, for the combination use of xyloglucan, hibiscus, and propolis, or Centaurii herba, Levistici radix, and Rosmarini folium to reduce recurrent cystitis episodes and antibiotic use. .

Background

Overview

Definition
Acute uncomplicated cystitis is a lower UTI occurring in the absence of anatomic or functional abnormalities of the urinary tract or any other complicating factors.
1
Pathophysiology
Acute uncomplicated cystitis is mostly caused by bacteria, including E. coli (86%), S. saprophyticus (4%), Klebsiella species (3%), Proteus species (3%), Enterobacter species (1.4%), Citrobacter species (0.8%), and Enterococcus species (0.5%).
2
Disease course
Bacterial infection of the lower urinary tract results in acute uncomplicated cystitis, which causes classic symptoms of dysuria, frequent voiding of small volumes, and urinary urgency. Occasional hematuria and suprapubic discomfort may be present.
2
Prognosis and risk of recurrence
Acute uncomplicated cystitis is not associated with an increase in mortality.
2

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of acute cystitis are prepared by our editorial team based on guidelines from the American Academy of Family Physicians (AAFP 2025,2024), the European Association of Urology (EAU 2025), the European Association of Urology (EAU/ESPU 2025), the American College of Obstetricians and Gynecologists (ACOG 2023), the Infectious Diseases Society of America (IDSA ...
Show more

Screening and diagnosis

Etiology
As per GUS 2018 guidelines:
Recognize that the most common cause of uncomplicated UTIs is E. coli, followed by S. saprophyticus, K. pneumoniae, and P. mirabilis. Recognize that other pathogens are rare.
A
Recognize that Enterococci are most commonly found in mixed infections, therefore, their pathogenicity is uncertain in uncomplicated UTIs.
B
Create free account

More topics in this section

  • Diagnostic criteria

  • Differential diagnosis

Classification and risk stratification

Severity assessment: as per GUS 2018 guidelines, use the Acute Cystitis Symptom Score to assess the severity of symptoms, the course of the disease over time, and the effect of therapy.
B

Diagnostic investigations

History and physical examination: as per AAFP 2025 guidelines, ask females with dysuria regarding vaginal symptoms, as the presence of vaginal discharge decreases the likelihood of UTI.
B

More topics in this section

  • Urinalysis

  • Urine culture

  • Urethrocystoscopy

  • Diagnostic imaging

Medical management

Antibiotic therapy, general principles: as per AAFP 2024 guidelines, consider prescribing a backup antibiotic (to be filled if symptoms do not improve within 48-72 hours or worsen at any time) in female patients with no signs of pyelonephritis or complicated infection not wishing to take antibiotics.
C

More topics in this section

  • Antibiotic therapy (first-line therapy)

  • Antibiotic therapy (second-line therapy)

  • Symptomatic management

Nonpharmacologic interventions

Fluid intake: as per AAFP 2024 guidelines, advise drinking at least 1.5 L of fluids daily in patients with a UTI.
B

More topics in this section

  • Herbal products

Specific circumstances

Pediatric patients, evaluation: as per EAU/ESPU 2025 guidelines, elicit a detailed medical history, assess clinical signs and symptoms, and perform a physical examination in the evaluation of children with suspected UTI.
A
Show 5 more

More topics in this section

  • Pediatric patients (management)

  • Pediatric patients (follow-up)

  • Pregnant patients (evaluation)

  • Pregnant patients (management)

  • Patients with antimicrobial-resistant UTI

  • Patients with Candida UTI

Preventative measures

Periprocedural antibiotic prophylaxis: as per EAU 2025 guidelines, do not use antibiotic prophylaxis to reduce the rate of symptomatic urinary infection following urodynamics, cystoscopy, or extracorporeal shockwave lithotripsy.
D
Show 4 more

Follow-up and surveillance

Post-treatment surveillance: as per SEIMC 2017 guidelines, do not obtain routine post-treatment cultures in asymptomatic female patients following treatment for cystitis.
D